Publications en collaboration avec des chercheurs de Instituto de Salud Carlos III (12)

2024

  1. Monkeypox virus genomic accordion strategies

    Nature Communications, Vol. 15, Núm. 1

2023

  1. Switching to bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) plus darunavir/cobicistat in heavily antiretroviral-experienced, virologically suppressed HIV-infected adults receiving complex regimens

    The Journal of antimicrobial chemotherapy, Vol. 78, Núm. 11, pp. 2696-2701

2022

  1. Discovering HIV related information by means of association rules and machine learning

    Scientific Reports, Vol. 12, Núm. 1

2021

  1. Late presentation for HIV impairs immunological but not virological response to antiretroviral treatment

    AIDS (London, England), Vol. 35, Núm. 8, pp. 1283-1293

  2. Standardized comparison of cardiovascular risk factors prevalence in spanish women and men living with hiv and in the general population

    Journal of Personalized Medicine, Vol. 11, Núm. 11

2020

  1. How well are we performing the initial assessment of HIV-positive patients? Results from a multicentre cohort in Spain

    HIV Medicine, Vol. 21, Núm. 2, pp. 128-134

2019

  1. CD4 recovery is associated with genetic variation in IFNγ and IL19 genes

    Antiviral Research, Vol. 170

  2. Implementing pre-exposure prophylaxis could prevent most new HIV infections in transsexual women and men who have sex with men

    Revista Clinica Espanola, Vol. 219, Núm. 7, pp. 360-366

2016

  1. Human immunodeficiency virus/hepatitis C virus coinfection in Spain: Prevalence and patient characteristics

    Open Forum Infectious Diseases, Vol. 3, Núm. 2

2014

  1. A low-cost, sustainable, second generation system for surveillance of people living with HIV in Spain: 10-year trends in behavioural and clinical indicators, 2002 to 2011

    Eurosurveillance, Vol. 19, Núm. 20

  2. Effects of switching from stavudine to raltegravir on subcutaneous adipose tissue in HIV-infected patients with HIV/HAART-Associated Lipodystrophy Syndrome (HALS). A clinical and molecular study

    PLoS ONE, Vol. 9, Núm. 2

2003

  1. Role of baseline human immunodeficiency virus genotype as a predictor of viral response to tenofovir in heavily pretreated patients

    Journal of Clinical Microbiology, Vol. 41, Núm. 9, pp. 4421-4423